Press releases
-
Read the press release (PDF, new tab)
-
Read the press release (PDF, new tab)
CROSSJECT Reports Its First-Half 2026 results
-
Read the press release (PDF, new tab)
CROSSJECT and BARDA align ZEPIZURE®’s Pediatric development plan with FDA including funding through 2030
-
Read the press release (PDF, new tab)
CROSSJECT announces the successful completion of an equity financing
-
Read the press release (PDF, new tab)
CROSSJECT appoints Lionel Seltz as Chief Financial Officer
-
Read the press release (PDF, new tab)
CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory
-
Read the press release (PDF, new tab)
CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group)